98% SVR12 in Korean and Taiwanese patients with chronic GT1 HCV infection receiving 12-weeks of ledipasvir/sofosbuvir: A phase 3 study

Rong-Nan Chien, Wan-Long Chuang, Cheng-Yuan Peng, Ting-Tsung Chang, Chi-Jen Chu, Jenny C. Yang, Horng-Yuan Wang, I-Shyan Sheen, Yu-Chun Hsu, Jia-Horng Kao

Research output: Contribution to journalJournal Article peer-review

Original languageAmerican English
Pages (from-to)20-20
JournalJournal of Gastroenterology and Hepatology
StatePublished - 2015

Cite this